Bristol Gate Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$64.7M |
| 2 |
Emcor
EME
|
+$64M |
| 3 |
W.R. Berkley
WRB
|
+$61.5M |
| 4 |
Howmet Aerospace
HWM
|
+$60.8M |
| 5 |
KLA
KLAC
|
+$51.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$66.9M |
| 2 |
Moody's
MCO
|
+$64.5M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$63.4M |
| 4 |
Intuit
INTU
|
+$60.1M |
| 5 |
Accenture
ACN
|
+$57.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 31.31% |
| 2 | Technology | 23.92% |
| 3 | Financials | 21.78% |
| 4 | Healthcare | 9.26% |
| 5 | Consumer Staples | 8.46% |
Similar funds
Bristol Gate Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Bristol Gate Capital Partners held 38 positions worth $1.44B, down 7.4% from $1.55B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bristol Gate Capital Partners withdrew a net $316M in Q2 2026, closing 5 positions and reducing 23 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $63.4M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
Against the trend, Bristol Gate Capital Partners opened a new position in Costco worth $60.7M.
- Bristol Gate Capital Partners's largest Q2 2026 buy was Costco: 64,911 shares worth $60.7M.
- Bristol Gate Capital Partners added most to Microsoft in Q2 2026, an estimated $9.46M increase.
- Bristol Gate Capital Partners's biggest Q2 2026 reduction was Sherwin-Williams, cutting an estimated $66.9M.
- Bristol Gate Capital Partners fully exited Thermo Fisher Scientific in Q2 2026, selling an estimated $63.4M.
- Bristol Gate Capital Partners's ten largest holdings make up 49% of its $1.44B portfolio in Q2 2026.
- Bristol Gate Capital Partners opened 7 new positions and closed 5 in Q2 2026.
- Bristol Gate Capital Partners's portfolio value fell 7.4% quarter-over-quarter to $1.44B.
Based on Bristol Gate Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.